Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes
- PMID: 17005329
- PMCID: PMC1865125
- DOI: 10.1016/j.drugalcdep.2006.08.027
Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes
Abstract
The relationship between psychiatric severity and substance use disorders treatment outcome was assessed in 393 individuals who received either standard treatment or standard treatment plus contingency management. The sample was divided into groups of low, moderate, and high psychiatric severity based upon baseline Addiction Severity Index psychiatric composite scores. Participants in the high psychiatric severity group reported a greater prevalence of psychiatric hospitalization, psychiatric medications, and suicide attempts, as well as poorer baseline psychosocial functioning. In terms of treatment outcome, a significant interaction between psychiatric severity and treatment modality was found in relation to treatment retention. Participants in the standard treatment condition were more likely to dropout of treatment earlier as psychiatric severity increased, while retention was similar across the psychiatric severity groups in the contingency management condition. Psychiatric severity was not linked to longest duration of abstinence achieved during treatment or adherence with contingency management procedures. Overall, these findings suggest contingency management is an efficacious and appropriate intervention for substance use disordered individuals across a range of psychiatric problems.
Figures


Similar articles
-
Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.Arch Gen Psychiatry. 2005 Oct;62(10):1148-56. doi: 10.1001/archpsyc.62.10.1148. Arch Gen Psychiatry. 2005. PMID: 16203960 Clinical Trial.
-
A meta-analytic review of psychosocial interventions for substance use disorders.Am J Psychiatry. 2008 Feb;165(2):179-87. doi: 10.1176/appi.ajp.2007.06111851. Epub 2008 Jan 15. Am J Psychiatry. 2008. PMID: 18198270
-
Contingency management treatments are equally efficacious for both sexes in intensive outpatient settings.Exp Clin Psychopharmacol. 2015 Oct;23(5):369-76. doi: 10.1037/pha0000035. Epub 2015 Jul 13. Exp Clin Psychopharmacol. 2015. PMID: 26167714 Free PMC article. Clinical Trial.
-
Outcome predictors in substance use disorders.Psychiatr Clin North Am. 2003 Jun;26(2):381-409. doi: 10.1016/s0193-953x(02)00106-5. Psychiatr Clin North Am. 2003. PMID: 12778840 Review.
-
"I's" on the prize: A systematic review of individual differences in Contingency Management treatment response.J Subst Abuse Treat. 2019 May;100:64-83. doi: 10.1016/j.jsat.2019.03.001. Epub 2019 Mar 7. J Subst Abuse Treat. 2019. PMID: 30898330 Free PMC article.
Cited by
-
Contingency Management Reduces Symptoms of Psychological and Emotional Distress among Homeless, Substance-dependent Men Who Have Sex with Men.Ment Health Subst Use. 2014 Nov 1;7(4):420-430. doi: 10.1080/17523281.2014.892897. Ment Health Subst Use. 2014. PMID: 25364379 Free PMC article.
-
Implementing an evidence-based prize contingency management protocol for stimulant use.J Subst Use Addict Treat. 2023 Aug;151:209079. doi: 10.1016/j.josat.2023.209079. Epub 2023 May 24. J Subst Use Addict Treat. 2023. PMID: 37230390 Free PMC article.
-
Therapeutic options and challenges for substances of abuse.Dialogues Clin Neurosci. 2007;9(4):431-45. doi: 10.31887/DCNS.2007.9.4/tgardner. Dialogues Clin Neurosci. 2007. PMID: 18286802 Free PMC article. Review.
-
Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.J Subst Abuse Treat. 2017 Jan;72:134-139. doi: 10.1016/j.jsat.2015.08.010. Epub 2015 Sep 21. J Subst Abuse Treat. 2017. PMID: 26482136 Free PMC article. Clinical Trial.
-
Exercise as an Adjunctive Treatment for Substance Use Disorders: Rationale and Intervention Description.J Subst Abuse Treat. 2017 Jan;72:40-47. doi: 10.1016/j.jsat.2016.09.002. Epub 2016 Sep 9. J Subst Abuse Treat. 2017. PMID: 27666958 Free PMC article. Review.
References
-
- Alterman AI, McLellan AT, Shifman RB. Do substance abuse patients with more psychopathology receive more treatment? J Nerv Ment Dis. 1993;181:576–582. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Author; Washington, DC: 1994.
-
- Angst J, Sellaro R, Merikangas KR. Multimorbidity of psychiatric disorders as an indicator of clinical severity. Eur Arch Psychiatry Clin Neurosci. 2002;252:147–152. - PubMed
-
- Applyby L, Dyson V, Altman E, Luchins D. Assessing substance use in multiproblem patients: Reliability and validity of the Addiction Severity Index in a mental hospital population. J Nerv Ment Dis. 1997;185:159–165. - PubMed
-
- Bottlender M, Soyka M. Outpatient alcoholism treatment: Predictors of outcome after 3 years. Drug Alcohol Depend. 2005;80:83–89. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DA013444/DA/NIDA NIH HHS/United States
- P50 AA003510/AA/NIAAA NIH HHS/United States
- T32-AA07290/AA/NIAAA NIH HHS/United States
- R01 DA014618/DA/NIDA NIH HHS/United States
- R01 DA022739/DA/NIDA NIH HHS/United States
- M01-RR06192/RR/NCRR NIH HHS/United States
- P50 DA009241/DA/NIDA NIH HHS/United States
- T32 AA007290/AA/NIAAA NIH HHS/United States
- R01 DA018883/DA/NIDA NIH HHS/United States
- P50-AA03510/AA/NIAAA NIH HHS/United States
- M01 RR006192/RR/NCRR NIH HHS/United States
- R01 MH060417/MH/NIMH NIH HHS/United States
- R01 DA016855/DA/NIDA NIH HHS/United States
- R01-DA14618/DA/NIDA NIH HHS/United States
- R01-DA016855/DA/NIDA NIH HHS/United States
- R01-MH60417/MH/NIMH NIH HHS/United States
- R01-DA13444/DA/NIDA NIH HHS/United States
- P50-DA09241/DA/NIDA NIH HHS/United States